As we delve deeper into the analysis of the proposed rule changes from the Centers for Medicare & Medicaid Services (CMS), many hospitals continue to struggle with the unintended effects of what initially appeared to be stronger patient protections in CMS-4208-F (MA 2026 Final Rule). While CMS has bolstered transparency, standardized the delivery of notices, and reinforced beneficiary appeal rights, Medicare Advantage (MA) plans have responded by shifting utilization management pressures back onto providers, tightening clinical, operational, and financial controls.
Examples of Operational Changes in MA Plans
A clear illustration of this trend is Aetna’s policy, which notably diverges from traditional inpatient denial workflows. More broadly, MA plans have made several significant operational adjustments, such as eliminating or restructuring denial-triggered peer-to-peer (P2P) pathways, shortening clinical submission timelines, and moving toward revised payment methodologies within standard Diagnosis-Related Group (DRG) contracts.
Causes for the Shift in MA Plan Strategies
It is uncertain whether this pivot is mainly a response to provider behaviors seen after CMS-4201-F—where hospitals increasingly escalated concurrent denials to P2P when the Two-Midnight Rule seemed to apply—or whether it is due to CMS-4208-F’s expectations for real-time beneficiary notification via the Integrated Denial Notice (IDN). Most likely, both factors have contributed to MA plans adjusting their strategies.
Purpose and Requirements of the Integrated Denial Notice (IDN)
The IDN is intended to combine multiple denial communications into a single, standardized notice, clearly outlining both coverage and payment decisions as well as related appeal rights. CMS requires MA plans to issue the IDN whenever there is an adverse organization determination, including during concurrent review.
The goal is to minimize confusion and ensure that beneficiaries receive consistent, actionable information when services are denied, reduced, or terminated.
Implications for Hospital Operations
This requirement has significant implications for hospitals. If an MA plan denies an inpatient level of care while the patient is still hospitalized, this determination must be treated as an adverse decision, triggering full notice and appeal rights.
CMS guidance emphasizes that patients must be informed in a timely and meaningful manner—even while still receiving care—so they have the opportunity to act on those rights during their hospital stay.
Challenges in Real-Time Notification
However, this requirement presents a practical challenge. When a patient is already admitted and receiving care, how can the IDN be effectively delivered in real time? It is unlikely that MA plans will hand-deliver notices, and relying on mailed communication increases the likelihood that the patient will be discharged before receiving the notice. This creates a gap between the regulatory intent and operational reality.
The Hospital’s Proactive Role
In light of this, hospitals may need to adopt a more proactive role. While the payer remains responsible for issuing the IDN, hospitals are often the only entity physically present with the patient at the time of the determination. Therefore, it may be reasonable and operationally necessary for hospitals to inform patients that their MA plan has denied an inpatient level of care and to reinforce their right to appeal.
Consideration of the Appointment of Representative (AOR) Form
At this point, an important consideration arises: should hospitals also provide the Appointment of Representative (AOR) form (CMS-1696)? Providing the AOR form at the time of a concurrent denial enables the patient to designate a representative—such as a family member or, when appropriate, hospital staff—to assist with the appeals process.
Although CMS does not mandate hospitals to distribute the AOR in this context, integrating it into the denial workflow is a practical strategy to support patient transparency and facilitate access to the member appeals process.
Advantages of Integrating the AOR Form
Including the AOR form alongside the IDN can offer several benefits. It ensures that patients and their families are not only aware of the denial but also prepared to take action. This approach provides a pathway to pursue appeals through the member process, which is essential given the increasingly limited provider appeal channels.
Most importantly, it aligns with CMS’s broader goal: ensuring beneficiaries are not only informed of their rights but also meaningfully supported in exercising them.
Operational Considerations
Of course, this approach introduces further operational considerations. Adding another form to case management and utilization review workflows requires additional training, standardization, and clear role definition.
Yet, as payers continue to tighten reimbursement, limit concurrent resolution options, and evolve denial methodologies, engaging patients and families as active participants in the appeals process may become a necessary change.
Source link: https://icd10monitor.medlearn.com/denied-in-real-time-rethinking-patient-advocacy-in-medicare-advantage/